Splash Beverage Group (NYSE: SBEV) stock jumped back into rally mode, adding about 12% since the start of the week. That happened for good reasons. SBEV is growing at its fasted rate in company history, is striking impressive distribution deals across the country with tier-one distributorships, has retail product placements in Walmart (NYSE: WMT), Target
ROSINBOMB (OTC: ROSN) stock is pressing out some impressive gains, surging over 100% higher to $0.022 a share since last week. For those just now getting turned on to ROSN, the company may seem like a typical penny stock long shot. However, ROSN differs from the familiar story, and its stock’s recent surge supports that
Camber Energy, Inc. (NYSE-Amer: CEI) stock is bucking a bearish smallcap trend, closing at $1.38 on Tuesday, higher by over 8% since the end of last week. Technically, CEI stock looks ready to break higher with continued bounces off its daily lows supporting the near-term likelihood for its bullish trend to continue. The first target
Publicly traded ROSINBOMB (OTC: ROSN) stock may be selling at penny levels now, but know this: a more thorough appraisal of the company’s inherent potential in a surging market can justify a case that ROSN shares are significantly undervalued. That disconnect exposes an opportunity. Whether investors seizing that opportunity translates to an immediate surge in
Splash Beverage Group (NYSE: SBEV) stock may be priced at smallcap levels, but on a sum of its parts bases, it’s anything but. In fact, SBEV is growing far faster and leveraging significantly more inherent value than its current $1.60 price represents. Plenty of evidence validates that assumption, even suggesting that SBEV is in its
Splash Beverage Group Is A Power Play, Recession-Proof Investment To Consider ($SBEV) Read More »
SOBR Safe, Inc. (NASDAQ: SOBR) stock is doing something most others aren’t…not feeding the bears. Instead, the bulls have taken the SOBR reigns, closing last week’s trading 5% higher despite decidedly bearish market conditions. In fact, SOBR is one of a small handful of stocks accruing any bullish momentum at all as investors fly from
SOBR Safe Inc. Is Not Feeding The Bears Here’s Why The Bulls Like The Stock ($SOBR) Read More »
SOBR Safe, Inc. (NASDAQ: SOBR) keeps getting stronger. Moreover, its stock has shown an uncanny ability to decouple from weakness in the broader markets. And there are reasons for that. Most recently, SOBR has shown that despite its small cap size, it can raise capital on shareholder-friendly terms. Few smallcaps, especially those with roughly $30
SOBR Safe Inc. Keeps Getting Stronger, Valuation Disconnect Exposed ($SOBR) Read More »
Shares of Inhibikase Therapeutics, Inc. (Nasdaq: IKT)c are in rally mode after announcing that the FDA lifted its full clinical hold on IkT-148009. On Tuesday, IKT shares continued their bullish trend, adding over 24% to $0.93 intraday. That adds to the more than 12% gain scored on Monday. Also of interest, both moves come with
Any weakness in Mainz Biomed’s (NASDAQ: MYNZ) share price presents an opportunity, especially ahead of several planned and potentially catalyst-fueled announcements. Investors had a chance to take MYNZ at prices 5% lower after its shares dropped, likely in sympathy with the Silicon Valley Bank (NASDAQ: SIVB) fiasco. However, shares are recovering quickly as investors realize
Mainz Biomed Needs To Be On Investor’s Radar Sooner Than Later…Here’s Why ($MYNZ) Read More »
Mainz Biomed’s (NASDAQ: MYNZ) share price consolidation at the $7.10 level may be ready to break – higher. Yes, that’s a bullish presumption, but it’s justified by recognizing how the groundwork completed in 2022 has set MYNZ up for a potentially transformative 2023. Current valuations might be fair if there were no forward-looking considerations, but
Mainz Biomed Attractive Ahead Of Data-Set Releases In 1H/2023 ($MYNZ) Read More »
